COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 1, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
FDA Approves Oral CGRP Inhibitor Atogepant for Prevention of Episodic Migraine
The daily oral CGRP inhibitor is the only agent in the class developed specifically for prevention vs acute treatment of episodic migraine.
Black Women with HIV at Highest Risk for Premature Mortality a 21-year Study Finds
IDWeek 2021: Despite declining mortality rates among patients with HIV in the past 2 decades, a new study finds significant disparities in gender and race.
Merck Oral Antiviral Reduces by Half the Risk of COVID-19 Hospitalization, Death in Vulnerable Adults
The positive results of the Merck MOVe-OUT phase 3 interim analysis of molnupiravir have led to an early halt to study recruitment, the company said Friday.
COVID-19 vs Influenza: A 7-question Quiz on Similarities and Differences
COVID-19 and influenza share a number of similarities but have key differences. Knowing how they differ will be the key to diagnosis this flu season. Get quizzed!
People Living with HIV Use Fewer Essential Clinical Services and Less Frequently During Pandemic
Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 30, 2021
CDI-specific Follow-up Visits Rare among Patients Hospitalized for Recurrence
IDWeek 2021: A new study found that only 16% of patients with CDI rehospitalized for recurrent infection had been seen in follow-up 30 days after original discharge.
Health Care Workers Likely to Recommend COVID-19 Vaccine to Patients Based on Safety Messaging, Survey Finds
Survey authors said findings merit further research into how to increase health care workers' confidence in discussing and recommending COVID-19 vaccines with patients.
Obesity May Put Children Hospitalized with COVID-19 at Higher Risk for Severe Disease, Suggests New Study
IDWeek 2021: Obesity prevention and vaccination efforts may help prevent COVID-19-related morbidity in pediatric COVID-19 patients with obesity, noted authors of a new study.
SUSTAIN-10 Post-hoc Analysis Suggests Additive Benefits for GLP-1 RA-SGLT-2i Combination
This post-hoc analysis showed increased reductions in A1c, weight, and BP in T2D patients prescribed GLP-1 receptor agonists who were already taking an SGLT-2 inhibitor.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 29, 2021
Low Prevalence of COVID-19 and Flu Coinfection Found in Real-world Cohort Study
Coinfection with influenza virus among COVID-19 patients was found to be rare in a new study presented at IDWeek 2021.
Reverse-dipping BP, Heart Rate Variability Linked to Increased All-cause Mortality in Diabetes
A pattern of nocturnal reverse-dipping blood pressure in persons with type 1 or 2 diabetes put them at more than twice the risk of all-cause mortality, according to new research.
IDWeek 2021: C diff Clinical Outcomes Unchanged after 2017 IDSA Guideline Update
IDWeek 2021: Use of vancomycin vs metronidazole increased after the 2017 IDSA recommendation but CDI recurrence rates increased slightly, investigators report.
Complex Regional Pain Syndrome: 11 Questions on Etiology, Diagnosis, Treatment
Complex regional pain syndrome is often a medical challenge. Try this in-depth quiz on the etiology, the differential diagnosis, and most effective therapies.
Sustained Weight Loss May Reverse CV Risk Factors Linked to Obesity, Study Shows
EASD 2021: For persons who have had obesity, returning to a healthy weight may reduce risk for hypertension and dyslipidemia, and modestly for diabetes.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 28, 2021
HCV Cure is Possible in Young Drug Users, Suggests New Research Being Presented at IDWeek 2021
IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.
Women with T2D Less Likely to Receive Guideline-recommended Cardiovascular Care vs Men
EASD 2021: Women with type 2 diabetes were less likely to meet targets for CV risk management vs men but at lower risk for future CV events, a new study found.